At the age of 20, it was decided to introduce insulin therapy, using a basal-bolus scheme after experiencing glycemic decompensation with symptoms of polyuria, polydipsia, and unexplained weight loss during steroid therapy. This evidence concerns the gene INS and Polyuria.